Get started
Author

Keita Kuroyanagi

The neutrophil‐to‐lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis
2023 · Sho Matoya, Takanori Suzuki, et al. · Hepatology Research · 24
PDF
Serum interleukin‐6 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced hepatocellular carcinoma: a multicenter analysis
2024 · Takanori Suzuki, Kentaro Matsuura, et al. · Journal of Gastroenterology and Hepatology · 11
PDF
Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis
2023 · Takanori Suzuki, Kentaro Matsuura, et al. · Cancer Medicine · 7
PDF
BRAF K601E-mutated metastatic colorectal cancer in response to combination therapy with encorafenib, binimetinib, and cetuximab: A case report
2024 · Makiko Sasaki, Takaya Shimura, et al. · World Journal of Gastrointestinal Oncology · 2
PDF
Clinical Impact of Proton Pump Inhibitor and Potassium-Competitive Acid Blocker for Predicting the Curability of Endoscopic Resection in Ulcerative Early Gastric Cancer
2024 · Konomu Uno, Takaya Shimura, et al. · Digestion · 1
A fatal case of hepatic portal venous gas following percutaneous endoscopic gastrostomy in a patient with systemic sclerosis–myositis overlap syndrome and pneumatosis cystoides intestinalis
2025 · Koji Uehara, Haruka Noda, et al. · Modern Rheumatology Case Reports
Works count: 6
Citation count: 45
H-index: 3
I10-index: 2
Year
Topic
Type